Wachovia upgrades OSI Pharmaceuticals (Nasdaq: OSIP) from Market Perform to Outperform and has a $45-$49 valuation range on the stock.
This article: 140 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE